| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |